Unknown

Dataset Information

0

Neristatin 1 provides critical insight into bryostatin 1 structure-function relationships.


ABSTRACT: Bryostatin 1, a complex macrocyclic lactone isolated from Bugula neritina, has been the subject of multiple clinical trials for cancer. Although it functions as an activator of protein kinase C (PKC) in vitro, bryostatin 1 paradoxically antagonizes most responses to the prototypical PKC activator, the phorbol esters. The bottom half of the bryostatin 1 structure has been shown to be sufficient to confer binding to PKC. In contrast, we have previously shown that the top half of the bryostatin 1 structure is necessary for its unique biological behavior to antagonize phorbol ester responses. Neristatin 1 comprises a top half similar to that of bryostatin 1 together with a distinct bottom half that confers PKC binding. We report here that neristatin 1 is bryostatin 1-like, not phorbol ester-like, in its biological activity on U937 promyelocytic leukemia cells. We conclude that the top half of the bryostatin 1 structure is largely sufficient for bryostatin 1-like activity, provided the molecule also possesses an appropriate PKC binding domain.

SUBMITTER: Kedei N 

PROVIDER: S-EPMC4415049 | biostudies-other | 2015 Apr

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC1965556 | biostudies-literature
| S-EPMC3713617 | biostudies-literature
| S-EPMC11216086 | biostudies-literature
| S-EPMC6481928 | biostudies-literature
| S-EPMC5599562 | biostudies-literature
| S-EPMC9709256 | biostudies-literature
| S-EPMC4825004 | biostudies-literature
| S-EPMC6504111 | biostudies-literature
| S-EPMC2143693 | biostudies-other
| S-EPMC5059453 | biostudies-literature